A Randomized Clinical Study of a Calcium-Entry Blocker (Lidoflzaine) in the Treatment of Comatose Survivors of Cardiac Arrest
NEJM 324:1225-1231, 1278-12801991., , 1991
Recurrent Attacks of Amaurosis Fugax Treated with Calcium Channel Blocker
Ann Neurol 30:423-425, Winterkorn,J.M.S.&Teman,A.J., 1991
Early Treatment of Ischemic Stroke with a Calcium Antagonist
Stroke 22:437-441, Rosenbaum,D.,et al, 1991
Atrial Fibrillation as an Independent Risk Factor for Stroke:The Framingham Study
Stroke 22:983-988, Wolf,P.A.,et al, 1991
Central Nervous System Reactions to Histamine-2 Receptor Blockers
Ann Int Med 114:1027-1034, Cantu,T.G.&Korck,J.S., 1991
Oral Anticoagulant Drugs
NEJM 324:1865-1875, Hirsh,J., 1991
The Effect of Flunarizine on Essential Tremor
Neurol 41:311-312, Biary,N.,et al, 1991
Nimodipine after Resuscitation from Out-of-Hospital Ventricular Fibrillation
JAMA 264:3171-3177, Roine,R.O.,et al, 1990
The Effect of Low-Dose Warfarin on the Risk of Stroke in Patients with Nonrheumatic Atrial Fibrillation
NEJM 323:1505-1511, 1556-15581990., Kistler,J.P.,et al, 1990
Nifedipine for Intractable Hiccups
Neurol 40:531-532, Lipps,D.C.,et al, 1990
Calcium Antagonists:Stroke Therapy Coming of Age
Stroke 21:494-501, Wong,M.C.W.&Haley,E.C., 1990
Thromboembolic Complications in Atrial Fibrillation
Stroke 21:4-13, Petersen,P., 1990
Preliminary Report of the Stroke Prevention in Atrial Fibrillation Study
Study Group, NEJM 322:863-8681990., , 1990
Autoantibodies to Gaba-Ergic Neurons & Pancreatic Beta Cells in Stiff-Man Syndrome
NEJM 322:1555-1560, Solimena,M.,et al, 1990
Treatment of Prolactin-Secreting Pituitary Macroadenomas with the Long-Acting Non-Ergot Dopamine Agonist CV 205-502
Ann Int Med 112:668-673, Vance,M.L.,et al, 1990
Acromegaly
NEJM 322:966-977, Melmed,S., 1990
Bromocriptine-Induced Hypothermia
Neurol 40:383, Pfeiffer,R.F., 1990
Subcutaneous Apomorphine in the Treatment of Parkinson's Disease
JNNP 53:96-101, Frankel,J.P.,et al, 1990
Nasogastric and Intravenous Infusions of (+) -4-propyl-9-hydroxynaphthoxazine (PHNO) in Parkinson's Disease
JNNP 53:102-105, 1990, Coleman,R.J.,et al, 1990
The Effect of Warfarin on Mortality and Reinfarction after Myocardial Infarction
NEJM 323:148-152, Smith,P.,et al, 1990
Anticoagulation:Is There Still a Role in Atherothrombotic Stroke
Stroke 21:820-824, Estol,C.J.&Pessin,M.S., 1990
Advances in Cluster Headache
Neurologic Clinics, 8:867-8901990., Mathew,N.T., 1990
Adverse Drug Effects on Neuromuscular Transmission
Semin Neurol 10:89-102, Howard,J.F., 1990
Pleural and Retroperitoneal Fibrosis from Dihydroergotamine
NEJM 321:1760, Malaquin,F.,et al, 1989
Drugs Acting on 5-Hydroxytryptamine Receptors
Editorial, Lancet 2:717-7191989., , 1989
Nifedipine in the Prophylaxis of Classic Migraine:A Crossover, Double-Masked, Placebo-Controlled Study of Headache
Neurol 39:284-286, McArthur,J.C.,et al, 1989
Prophylactic Treatment of Cluster Headache with Verapamil
Headache 29:167-168, Gabai,I.J.&Spierings,L.H., 1989
Nifedipine and Myoclonic Disorders
Nephron 51:281, Pedro-Botet,M.L.,et al, 1989
Effect of Nimodipine on Cerebral Infarction & Outcome after Subarachnoid Haemorrhage:British Aneurysm Nimodipine Trial
BMJ 298:636-642, Pickard,J.D.,et al, 1989
Placebo-Controlled, Randomised Trial of Warfarin & ASA for Prevention of Thromboembolic Complic in Chronic A Fib
Lancet 1:175-179, Petersen,P.,et al, 1989
Bromocriptine in Parkinson's Disease:A Double-Blind Study Comparing"Low-Slow"and"High-Fast"in de Novo Patients
UK Bromocriptine Res Group, JNNP 52:77-821989., , 1989
Lisuride, A Dopamine Agonist in the Treatment of Early Parkinson's Disease
Neurol 39:336-339, Rinne,U.K., 1989
Diltiazem-Induced Parkinsonism
Am J Med 87:95-96, Dick,R.S.&Barold,S.S., 1989
Pergolide and Selegiline for Parkinson's Disease
The Medical Letter, 31:81-841989., , 1989
Agonist Substitution in Advanced Parkinson's Disease
Neurol 39:1121-1122, Goetz,C.G.,et al, 1989
Physiology & Pharmacology of Dopamine D2-Receptors:Their Implications in Dopamine-Substitute Therapy for Park
Neurol 39:1106-1108, Mercuri,N.B.,et al, 1989
Postmortem Analysis of Adrenal-Medulla-to-Caudate Autograft in a Patient with Parkinson's Disease
Ann Neurol 25:607-614, Hurtig,H.,et al, 1989
The Efficacy of (+) -4-Propyl-9-Hydroxynaphthoxazine as Adjunctive Therapy in Parkinson's Disease
JNNP 52:732-735, Weiner,W.J.,et al, 1989
Neuroleptic Malignant Syndrome, Review of Response to Therapy
Arch Int Med 149:1927-1931, Rosenberg,M.R.&Green,M., 1989
PHNO[ (+) -4-Propyl-9-Hydroxynaphthoxazine]:A New and Effective Anti-Parkinson's Disease Agent
Neurol 38:1541-1545, Muenter,M.D.,et al, 1988
Role of Subcutaneous Apomorphine in Parkinsonian Voiding Dysfunction
Lancet 2:1451-1453, Christmas,T.J.,et al, 1988
Hyperprolactinaemia, Common and Treatable
BMJ 297:701-702, Hartog,M.&Hull,M.G.R., 1988
Parkinsonism, Tremor, and Depression Induced by Cinnarizine and Flunarizine
BMJ 297:722-723, Capella,D.,et al, 1988
Hyperhidrosis & Hypothermia Responsive to Oxybutynin
Neurol 38:506-507, LeWitt,P., 1988
Combination of Aminocaproic Acid & Nicardipine in Treatment of Aneurysmal Subarachnoid Hemorrhage
Stroke 19:63-67, Beck,D.W.,et al, 1988
A Controlled Trial of Nimodipine in Acute Ischemic Stroke
NEJM 318:203-207, Gelmers,H.J.,et al, 1988
Tardive Dyskinesia
BMJ 296:150-151, Barnes,T.R.E., 1988
Neonatal Myasthenia Gravis:A New Clinical & Immunologic Appraisal on 30 Cases
Neurol 38:138-142, Morel,E.,et al, 1988
International Symposium on Early Dopamine Agonist Therapy of Parkinson's Disease
Arch Neurol 45:204-208, Kurlan,R., 1988
Subcutaneous Apomorphine in Parkinsonian On-Off Oscillations
Lancet 1:403-406, Stibe,C.M.H.,et al, 1988